[Effects of a beta blockader (SD/1601) associated with a tranquilizing agent (Camazepam) on systemic and coronary hemodynamic modifications due to induced emotional stress in the conscious dog].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects; D004285:Dogs; D004357:Drug Synergism; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D011412:Propanolamines / Q000494:pharmacology*; D013315:Stress, Psychological / Q000502:physiology*; D013693:Temazepam / Q000494:pharmacology*; D014851:Wakefulness
D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D011412:Propanolamines; D013693:Temazepam
Effetto di un farmaco beta-bloccante (SD/1601) associato ad un tranquilizzante (Camazepam) sulle modificazioni emodinamiche sistemiche e coronariche indotte nel cane sveglio da stress emotivi.